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The framework of the newly revised International Health 
Regulations is a key driver in the effort to strengthen global 
public health security. Unanimously agreed upon by the 
World Health Assembly on May 23, 2005, the regulations 
are the result of experience gained and lessons learned dur-
ing the past 30 years. This global legal framework includes 
a commitment from the World Health Organization (WHO) 
and from each WHO member state to improve capacity for 
disease prevention, detection, and response. It provides 
standards for addressing national public health threats that 
have the potential to become global emergencies. Its suc-
cess will rely on the capacity and performance of national 
public health systems, anchored by strong national public 
health institutes (NPHIs). The new International Association 
of National Public Health Institutes aims to strengthen and 
invigorate existing NPHIs, to create new NPHIs where none 
exist, and to provide funded grants to support NPHI devel-
opment priorities.
I
n the wake of the 2003 outbreak of severe acute respira-
tory syndrome (SARS), preparedness for public health 
emergencies was propelled into worldwide consciousness. 
The appearance and rapid international spread of SARS 
demonstrated to all—including global leaders, ministers of 
health, prime ministers, and heads of state—how an infec-
tious disease can rapidly cross borders and deliver health 
threats and economic blows on an unimaginable scale (1,2). 
Since then, the entrenchment of highly pathogenic avian in-
ﬂ  uenza virus (H5N1) in poultry ﬂ  ocks of Asian countries, 
and the spread of the virus across Europe and into Africa, 
has put the world on high alert for an inﬂ  uenza pandemic 
and afﬁ  rmed the urgency of strengthening public health 
systems and capacity worldwide (3,4).
Compounding the challenges of threats to public health 
security from new and reemerging infectious diseases and 
the concerns about intentional dissemination of chemical 
or biological substances are the challenges of ensuring in-
dividual health security. These latter challenges include the 
unﬁ  nished agenda of broadening access to the drugs, vac-
cines, and other interventions needed to control endemic 
diseases such as malaria, acute lower respiratory tract in-
fections, diarrheal diseases, measles, and tuberculosis, as 
well as to address the ongoing problems of HIV/AIDS, 
neglected tropical diseases, humanitarian emergencies, and 
global environmental changes.
The scale, range, and complexity of these modern 
challenges to health security call for new approaches of 
comparable dimension and strength. Protecting the world 
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from transnational health threats demands a global public 
health perspective and investment in global public health 
infrastructure. The theme of this year’s World Health Day 
and the World Health Report 2007 is “Global public health 
security—the need to reduce the vulnerability of people 
around the world to new, acute, or rapidly spreading risks 
to health, particularly those that cross international bor-
ders” (5). With a call to all nations to “invest in health, 
and build a safer future,” the World Health Organization 
(WHO) emphasizes the need for collaboration among na-
tions to increase our collective capacity and infrastructure 
to respond to potential international health emergencies 
and other public health risks. As recent events have shown, 
global public health security is a complex, costly, and in-
formation-intense undertaking that requires strong national 
public health leadership and infrastructure, cross-border 
collaboration, capacity to identify problems rapidly and de-
sign real-time evidence-based solutions, well-trained and 
well-equipped workforces, well-functioning laboratories 
and service-delivery systems, capacity to sustain interven-
tions, and ability to respond to unexpected events (5,6). In-
vestment in these elements will strengthen not only global 
public health security but also the infrastructure needed to 
help broaden access to healthcare services and improve in-
dividual health outcomes, which would help break the cy-
cles of poverty and political instability and thus contribute 
to national economic development and achievement of the 
Millennium Development Goals (7).
A key driver in the effort to strengthen global public 
health security is the framework of the newly revised Inter-
national Health Regulations (IHR [2005]) (8), the legally 
binding global agreement designed to build and strengthen 
national alert and response systems. Unanimously agreed 
upon by the World Health Assembly on May 23, 2005, the 
regulations are the result of experience gained and lessons 
learned about global public health security over the past 30 
years. This global legal framework constitutes a “major de-
velopment in the use of international law for public health 
purposes” (9). It includes a commitment from WHO and 
from each of its 193 member states to improve capacity for 
disease prevention, detection, and response and provides 
ground rules to address national public health threats that 
have the potential to become global emergencies. The adop-
tion of the new regulations ended a 10-year process of revi-
sion, stimulated by the pneumonic plague outbreak in India 
in 1994 (10) and the Ebola hemorrhagic fever outbreak in 
the former Zaire in 1995 (11). The revised regulations have 
now entered into force for all WHO member states.
New Times, New Requirements
The revised regulations reﬂ  ect a growing understand-
ing that the best way to prevent the global spread of dis-
eases is to detect and contain them while they are still local. 
WHO member states have obligations to rapidly assess and 
alert the global community about potential disease threats 
as well as to prevent and control the spread of disease in-
side and beyond their borders. Compared with the previ-
ous regulations, adopted in 1969 (12), IHR (2005) expands 
the scope of internationally reportable diseases and events, 
provides criteria for identifying novel epidemic events, and 
speciﬁ  es conditions for involvement of the international 
community in outbreak responses. The revision includes 
the following 5 substantive changes.
Expanded Scope
The previous regulations applied to only 3 infectious 
diseases: cholera, plague, and yellow fever. IHR (2005) 
reﬂ   ects shifting concepts about disease control, shaped 
by recent and impending disease threats and the experi-
ences of the past 2 decades in detecting and responding to 
disease outbreaks. The emergence and reemergence of a 
cascade of infectious diseases fueled by globalization and 
international travel (13), the threat of biological terrorism, 
and novel environmental threats (14) have spotlighted the 
need for heightened vigilance and increased capacity to 
recognize and manage public health risks and emergencies. 
The appearance and rapid international spread of SARS 
and the pandemic potential of circulating avian inﬂ  uenza 
(H5N1) strains—with their combined health and economic 
effects—conﬁ  rmed the inapplicability of the 1969 IHR to 
most emerging and reemerging infectious diseases.
The revised regulations replace the previous disease-
speciﬁ  c framework with one built on timely notiﬁ  cation of 
all events that might constitute a public health emergency 
of international concern, taking into account the context in 
which an event occurs (15). The advantage of this approach 
is its applicability to existing threats as well as to those that 
are new and unforeseen. The regulations also recognize the 
existence of threats to public health outside the infectious 
disease context, such as those associated with natural di-
sasters, industrial or chemical accidents, and other environ-
mental changes, which might cross international borders.
Decision Instrument and Notiﬁ  cation
Expanding the scope of the IHR beyond reporting of 3 
diseases to reporting of any public health emergency of in-
ternational concern required an algorithm to assist in iden-
tiﬁ  cation of such events. The resulting decision instrument 
(see [8], Annex 2, p. 43) identiﬁ  es a limited set of criteria 
for use by member states for fulﬁ  lling the obligation to de-
termine whether an event occurring within their territory 
might constitute a public health emergency of international 
concern and therefore require formal notiﬁ  cation to WHO 
within 24 hours of assessment. Essentially, the events that 
must be reported are those that fulﬁ  ll at least 2 of the fol-
lowing criteria:Global Public Health Security
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• Is the public health impact of the event serious?
• Is the event unusual or unexpected?
• Is there a signiﬁ  cant risk of international spread?
• Is there a signiﬁ  cant risk of international trade or 
travel restriction?
To facilitate the use of the decision instrument, which 
requires some judgment to answer each of the questions, 
Annex 2 of the Regulations provides speciﬁ  c examples of 
events that might constitute a public health emergency of 
international concern. In addition to this broad scope for 
notiﬁ   cation, IHR (2005) includes a list of diseases for 
which a single case must be reported to WHO immediate-
ly, regardless of the context in which the disease occurs. 
This list includes smallpox, poliomyelitis due to wild-type 
poliovirus, human inﬂ  uenza caused by a new subtype, or 
SARS. In addition, an event involving certain other dis-
eases (e.g., cholera, pneumonic plague, yellow fever, vi-
ral hemorrhagic fevers) calls for a careful evaluation using 
the decision instrument to determine whether notiﬁ  cation 
is indicated. The need for recognition of speciﬁ  c diseases 
requires adequate diagnostic laboratory capacity.
After an event is reported, only the Director General 
of WHO can determine whether the event formally consti-
tutes a public health emergency of international concern. 
However, the Director General shall ﬁ  rst consult with the 
affected state party and hear the view of the emergency 
committee. This committee, composed of experts from the 
newly established IHR roster of experts, is speciﬁ  cally set 
up to review a reported event and provide advice to the 
Director General on whether an event constitutes a pub-
lic health emergency of international concern and whether 
a temporary recommendation must be issued. On request, 
WHO will be able to provide technical support to affected 
countries, including the mobilization of the Global Out-
break Alert and Response Network. 
Focal and Contact Points
A third innovation under IHR (2005) is the require-
ment for member states to designate “national IHR focal 
points” as the operational link for notiﬁ  cation and report-
ing to WHO and for WHO to name corresponding “IHR 
contact points.” Effective communication between these 2 
organizational entities will be central to the rapid manage-
ment of a possible public health emergency of international 
concern. IHR focal points, or their designees, are required 
by IHR (2005) to be accessible at all times.
National Core Surveillance and Response Capacities
Experiences during the past several years have shown 
that public health emergencies expose the weaknesses and 
vulnerabilities of national and subnational public health 
infrastructure. The fourth change calls for member states 
to develop, strengthen, and maintain core capacities to 1) 
detect, assess, notify, and report disease events, and 2) re-
spond promptly and effectively to public health risks and 
public health emergencies of international concern. State 
parties are required to complete a capacity assessment 
within 2 years of the revised IHR entering into force and, 
after this assessment, to develop public health infrastruc-
ture and human resources that ensure full compliance with-
in 5 years of the IHR entering into force. This assessment 
must lead to the development of national action plans to 
meet the core capacity requirements that Annex 1 of the 
Regulations speciﬁ  es for different levels (i.e., local com-
munity or primary, intermediate, and national public health 
response) as well as designated airports, ports, and ground 
crossings. For these national points of entry, IHR (2005) 
also introduces special provisions for travelers, including 
the obligation to treat them with respect for their dignity, 
human rights, and fundamental freedom. 
WHO Support  
WHO is required to assist all member states in fulﬁ  ll-
ing the new obligations. On request, WHO will collabo-
rate with countries to evaluate their public health capaci-
ties and facilitate technical cooperation, logistical support, 
and mobilization of ﬁ  nancial resources for strengthening 
capacity in surveillance and response. Countries will build 
on existing national or regional strategies such as the Asia 
Paciﬁ  c Strategy for Emerging Diseases in WHO’s South-
east Asia and Western Paciﬁ  c Regions (16) and the Inte-
grated Disease Surveillance and Response strategy in the 
African Region (17). In many countries, national action 
plans can also build on the inﬂ  uenza pandemic prepared-
ness plans developed with WHO’s guidance. Speciﬁ  c 
WHO guidelines and initiatives, particularly in the areas of 
external quality assessment for laboratories, data gathering 
and analysis at the health district level, and the central and 
coordination functions of national public health institutes, 
are being developed. WHO’s Lyon Ofﬁ  ce for National Epi-
demic Preparedness and Response is speciﬁ  cally dedicated 
to supporting countries in meeting the core national capac-
ity requirements of IHR (2005).
Under IHR (2005), new powers for WHO include an 
information-gathering responsibility that is not limited 
solely to ofﬁ   cial state notiﬁ   cations or consultations but 
covers all available scientiﬁ  c evidence and other relevant 
information. WHO can consult nonofﬁ   cial reports and 
require countries to collaborate with a request for veriﬁ  -
cation. WHO is also empowered to recommend and co-
ordinate measures that will help contain the international 
spread of disease, including public health actions at ports, 
airports, and land borders, and on means of transportation 
that involve international travel.GLOBAL POVERTY  POLICY REVIEW
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Critical Role of National Public Health Institutes
Because weak national public health capabilities un-
dermine efforts to strengthen global public health security, 
IHR (2005) imposes substantial responsibilities on coun-
tries to improve public health capacity and infrastructure. 
However, despite the broad new goals included in IHR 
(2005), improvements in global public health security will 
depend on what member states are actually able to do. Suc-
cess will rely on the capacity and performance of national 
public health systems (15), anchored by strong national 
public health institutes (NPHIs). Low-resource countries, 
which are particularly vulnerable to emerging threats, will 
be particularly challenged by the IHR (2005) requirements 
and the need to ensure an appropriate and coordinated pub-
lic health response to health emergencies.
Many countries have been well served by centralizing 
their public health expertise and activities within 1 institu-
tion or network of institutions that provides leadership and 
coordination for public health (18; unpub. data). Examples 
include the US Centers for Disease Control and Prevention, 
the National Public Health Institute of Finland, and the 
Chinese Center for Disease Control and Prevention. These 
NPHIs are usually governmental or quasi-governmental 
agencies with a central focus and organizational structure 
that allow coordination of national public health service de-
livery and ensure a country’s ability to detect, investigate, 
and respond to public health emergencies. The core func-
tions of an NPHI have been deﬁ  ned (unpub. data) and in-
clude evaluation and analysis of health status; public health 
surveillance, problem investigation, and control of risks 
and threats to public health; and public health research.
Given the scope and range of their activities, NPHIs 
are a vital asset to health development and security and 
will have a critically important role in implementing IHR 
(2005), whether as national focal points or as operational 
partners in fulﬁ  lling the requirements of the regulations. 
Unfortunately, however, many countries still either have no 
NPHIs or have institutes with severely limited capacities 
and capabilities relative to the need. Even in countries with 
strong NPHIs, unpredictable and rapidly evolving health 
threats can quickly overwhelm capacity and inhibit a time-
ly and complete response.
A new organization, the International Association of Na-
tional Public Health Institutes (IANPHI, www.ianphi.org), 
was created to address these gaps through the enhancement 
and proliferation of NPHIs throughout the world. Founded in 
2006 by 39 NPHI directors who recognized the importance 
of strong national public health capacity and the mutual 
beneﬁ  ts of shared information, experience, and expertise, 
IANPHI aims to be a catalyst for sustained improvements in 
public health capacity and infrastructure globally. With the 
partnership of WHO and funding ﬁ  rst from the Rockefeller 
Foundation and now from the Bill and Melinda Gates Foun-
dation, the organization focuses on strengthening public 
health capacity in low-resource countries by strengthening 
NPHIs and on providing tools and a context that will sup-
port all NPHIs. IANPHI is also a professional association for 
NPHI directors; it fosters leadership development and advo-
cacy for public health and collaborates with WHO.
Since early 2006, the founding members have contin-
ued to expand the network and put their shared vision into 
practice. IANPHI is managed by an executive board and a 
secretariat located both in Finland and in the United States. 
With nearly 50 current members and an ambitious agenda 
for collaboration, service, and growth, IANPHI is commit-
ted to a vision of a robust and fully integrated global net-
work of NPHIs equipped to address critical public health 
challenges. Its mission is to strengthen and reinvigorate 
existing NPHIs, create new NPHIs where none exist, and 
provide funded grants to support NPHI capacity develop-
ment priorities.
IANPHI achieves its service mission through a 3-
part approach of advocacy, technical assistance, and 
linkages. IANPHI advocates for NPHI development 
and proliferation through partnerships with key global 
health organizations, such as WHO. Through these part-
nerships, IANPHI ensures that NPHIs are considered 
in major global public health initiatives and that public 
health and the work of NPHIs are included in efforts to 
strengthen health systems.
Assistance to NPHIs in low-resource countries is pro-
vided through 3 grant programs. A short-term technical as-
sistance program helps countries quickly resolve priority 
gaps in NPHI capability and infrastructure. A medium-term 
capacity-building program helps NPHIs address high-pri-
ority needs for up to 3 years. IANPHI’s long-term grant 
program, the most intensive of the assistance efforts, will 
help create NPHIs in low-resource countries that currently 
lack a central public health focus. With funding from a $20 
million grant from the Bill and Melinda Gates Foundation, 
the organization is committed to implementing 60 NPHI 
development projects by 2011.
As of June 2007, IANPHI had awarded technical assis-
tance grants to public health institutes in 5 nations. The new 
awards include 3 short-term grants to NPHIs in Thailand, 
Uganda, and Iran to support training and infrastructure de-
velopment. A medium-term grant to the Nigerian Institute 
of Medical Research will support sustainable improve-
ments in disease surveillance, outbreak investigation, and 
emergency preparedness and strengthen linkages with oth-
er groups working to advance public health in the country; 
special focus will be on public health laboratory capacity 
building and integration of surveillance, epidemiology, and 
laboratory programs. Colombia’s Institutos Nacional de 
Salud was awarded a medium-term grant to establish a pilot 
chronic disease study site to generate, collect, and dissemi-Global Public Health Security
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nate chronic disease data by using multiple mechanisms. 
The activities are designed to yield a sustainable network of 
surveillance and research sites to guide national-level pub-
lic health decision making.
The cornerstone of the IANPHI approach is a peer-assis-
tance model for NPHI strengthening and enhancement, with 
an emphasis on countries without NPHIs or with NPHIs in 
their early stages. Experts from IANPHI member institutes 
provide technical assistance and project support targeted at 
critical NPHI needs. Teams are guided by the Framework 
for the Creation and Development of NPHIs (www.ian-
phi.org/?action=arkisto&RYHMA=47&ID=&valittu=8), a 
product of IANPHI in partnership with WHO. The Frame-
work provides a working deﬁ  nition of an NPHI and sug-
gests a process for creating or enhancing an institute. By 
deﬁ  ning the critical characteristics of an NPHI, IANPHI 
hopes to bring speciﬁ  city to the organization’s vision, align 
efforts to assist low-resource countries in building NPHIs, 
and provide benchmarks and resources to help any country 
assess and improve the functioning of its NPHI. To that 
end, IANPHI has also developed an NPHI toolkit (www.
sph.emory.edu/IANPHI), which provides access to a va-
riety of Web-based information resources for countries, 
NPHIs, and IANPHI peer-assistance teams to use as they 
work to assess, develop, and improve NPHIs and build 
public health capacity around the world.
Through strategies to deﬁ  ne and develop core pub-
lic health functions and to share expertise, IANPHI helps 
NPHIs sharpen their focus and raise standards of perfor-
mance. IANPHI also links NPHIs through annual meet-
ings, regional events, leadership development activities, 
research seed grants, and communication outlets including 
a website, newsletter, and listserv. By fostering an inter-
national community of public health leadership, IANPHI 
helps NPHIs gain the beneﬁ  ts of shared information, ex-
perience, and expertise to address public health threats and 
opportunities. Through its grant program and other activi-
ties, IANPHI aims to help national governments develop 
organizational infrastructures to devise and implement 
comprehensive public health priorities, meet global public 
health goals, develop workforce capacity, effectively ab-
sorb donor funds, address emerging threats, and improve 
the health of their populations (18).
Conclusions
In today’s global environment, every country con-
fronts similar challenges in keeping its population healthy 
and preventing the cross-border spread of disease. SARS 
demonstrated this dramatically in 2003, and the ongoing 
challenges posed by avian inﬂ  uenza have focused atten-
tion on the need for global pandemic inﬂ  uenza prepared-
ness. Polio has reemerged in countries that had virtually 
eradicated it, while HIV/AIDS and other diseases continue 
to threaten the stability of communities around the world. 
Recent examples of emerging and reemerging diseases of 
global signiﬁ  cance are the resurgence of dengue in tropi-
cal and subtropical areas of the world; the spread and es-
tablishment of Japanese encephalitis and West Nile viruses 
in new habitats and environments; and the reoccurrence 
and spread of chikungunya virus in India, East Africa, and 
several Indian Ocean islands (19,20). As life expectancy 
increases worldwide, issues related to noncommunicable 
conditions are also becoming increasingly common to all. 
By working within the collaborative framework provided 
by IHR (2005), countries can beneﬁ  t through improved na-
tional and international surveillance; improved systems for 
rapid detection of and response to public health emergen-
cies; standardized rules for evaluation, control, and resolu-
tion of urgent events; and mechanisms to increase national 
and local public health security.
Nonetheless, the success of IHR (2005) and other glob-
al public health initiatives such as the Millennium Devel-
opment Goals depends on strong national public health sys-
tems with competent, well-trained staff and well-equipped 
facilities. By targeting the core of public health systems, es-
pecially in low-resource countries that currently lag behind 
in public health capacity and infrastructure, IANPHI will 
play a key role in improving the capacity of countries to 
effectively detect, investigate, and respond to public health 
emergencies. The result will be better control of endemic 
diseases such as HIV/AIDS, acute lower respiratory tract 
infections, diarrheal diseases, measles, tuberculosis, ma-
laria, and the neglected tropical diseases. These efforts will 
strengthen the practice of public health worldwide, yield 
global public health beneﬁ  ts of disease control and preven-
tion, and ultimately accelerate social and economic devel-
opment in the poorest countries of the world and progress 
toward achieving the Millenium Development Goals.
Dr Rodier is director of International Health Regulations co-
ordination at WHO in Geneva. 
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